James E. Tisdale, PharmD, BCPS, FCCP

Dr. Tisdale received his B.Sc. Pharm from the University of Manitoba in 1983 and his Pharm.D. from S.U.N.Y. at Buffalo in 1988. He completed a pharmacy practice residency at the University of Manitoba Health Sciences Centre in 1984 and a Fellowship in Cardiovascular Therapeutics at Hartford Hospital (CT) from 1988-1990. He is currently Professor of Pharmacy Practice in the Department of Pharmacy Practice at the Purdue University School of Pharmacy and Pharmaceutical Sciences and Adjunct Professor, School of Medicine, Indiana University in Indianapolis, Indiana.

Dr. Tisdale’s research interests are in the area of cardiovascular pharmacotherapy, focusing on: mechanisms, risk factors, and management of drug-induced arrhythmias, and drug therapy for prevention and treatment of atrial fibrillation. His research has resulted in the publication of over 50 journal articles, 11 book chapters and over 40 research abstracts in addition to his co-editorship of Drug-Induced Diseases. Prevention, Detection and Management.

Dr. Tisdale’s research has been funded by the American Heart Association, numerous foundations, and the pharmaceutical industry. From 2001-2004, he was a member of the Board of Regents of the American College of Clinical Pharmacy, and from 2008-2009 he was Chair, Clinical Sciences Section, Academy of Pharmaceutical Research and Science, American Pharmacists Association (APhA). Dr. Tisdale is currently President-Elect of the American College of Clinical Pharmacy (ACCP).